Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials.
about
Atherosclerosis and infection: is the jury still not in?Antibiotics for secondary prevention of coronary heart diseaseGut flora metabolism of phosphatidylcholine promotes cardiovascular diseaseThe Metabolic Role of Gut Microbiota in the Development of Nonalcoholic Fatty Liver Disease and Cardiovascular DiseaseRole of Nucleotide-binding and Oligomerization Domain 2 Protein (NOD2) in the Development of AtherosclerosisTherapeutic targeting of NOD1 receptorsPeripheral artery disease: epidemiology and global perspectives.Clarithromycin for 2 weeks for stable coronary heart disease: 6-year follow-up of the CLARICOR randomized trial and updated meta-analysis of antibiotics for coronary heart diseaseImpact of sepsis on risk of postoperative arterial and venous thromboses: large prospective cohort study.Effects of intra-abdominal sepsis on atherosclerosis in miceRandomised placebo controlled multicentre trial to assess short term clarithromycin for patients with stable coronary heart disease: CLARICOR trialFar from the eyes, close to the heart: dysbiosis of gut microbiota and cardiovascular consequences.The gut microbiota, environment and diseases of modern society.Improvement in daytime sleepiness with clarithromycin in patients with GABA-related hypersomnia: Clinical experience.VSL#3 resets insulin signaling and protects against NASH and atherosclerosis in a model of genetic dyslipidemia and intestinal inflammation.Blood microbiota dysbiosis is associated with the onset of cardiovascular events in a large general population: the D.E.S.I.R. study.Atherosclerosis and Alzheimer--diseases with a common cause? Inflammation, oxysterols, vasculaturePathogen sensing pathways in human embryonic stem cell derived-endothelial cells: role of NOD1 receptors.Gut microbiota and diabetes: from pathogenesis to therapeutic perspective.Helicobacter pylori Infection Increases Insulin Resistance and Metabolic Syndrome in Residents Younger than 50 Years Old: A Community-Based StudyDetection by broad-range real-time PCR assay of Chlamydia species infecting human and animals.Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk.Infection with Chlamydia pneumoniae as a cause of coronary heart disease: the hypothesis is still untestedAbsence of Bacteria on Coronary Angioplasty Balloons from Unselected Patients: Results with Use of a High Sensitivity Polymerase Chain Reaction Assay.Mechanisms involved in the association between periodontal diseases and cardiovascular diseaseBacterial Communities Associated with Atherosclerotic Plaques from Russian Individuals with AtherosclerosisManaging Cardiovascular Risk of Macrolides: Systematic Review and Meta-Analysis.Neovascularization of coronary tunica intima (DIT) is the cause of coronary atherosclerosis. Lipoproteins invade coronary intima via neovascularization from adventitial vasa vasorum, but not from the arterial lumen: a hypothesis.Toll-like receptors and human disease: lessons from single nucleotide polymorphisms.The interaction of bacterial pathogens with platelets.Development potential of rifalazil and other benzoxazinorifamycins.Chlamydophila pneumoniae infection and cardiovascular diseaseA meta-analysis of antibiotic use for the secondary prevention of cardiovascular diseasesStrengthening causal inference in cardiovascular epidemiology through Mendelian randomization.The prospective association of Chlamydia pneumoniae and four other pathogens with development of coronary artery calcium: the multi-ethnic study of atherosclerosis (MESA).Individual pathogens, pathogen burden and markers of subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis.Blood dendritic cells: "canary in the coal mine" to predict chronic inflammatory disease?Invasion of oral and aortic tissues by oral spirochete Treponema denticola in ApoE(-/-) mice causally links periodontal disease and atherosclerosis.Why should a doctor be interested in oral disease?Recent advances in technologies for developing drugs against Chlamydia pneumoniae.
P2860
Q22241306-2A1817CB-536E-4A05-935F-2BE19A202C44Q24201388-6A843875-C44F-48C5-96A4-88873E9EAECFQ24601951-45C2231A-165C-4128-85F9-FC51BE54186EQ26739993-AA6A5D76-A9E0-468E-BDB6-2A481A732C78Q26777991-5CDF924D-5530-4565-904F-96EB70080E9BQ28676201-748F9570-3573-4D70-9AFB-4393B4B8B2C4Q30241154-6AF0D99D-4033-4559-A811-B947F720C077Q33646625-991C2B6A-C245-4620-BCDB-10E543D0B8B5Q34148677-EBEA23DA-E4D6-44DB-B3F8-E47367EF58C7Q34234151-8EDB241F-BE43-4498-BAFB-34796F19D1D1Q34248742-7E95F093-D830-4E05-8084-B4FD54E546C8Q34324267-B719E90D-880E-4B05-8F7E-AB969B61BEF8Q34348985-A057AF2A-CCC4-4F0D-983D-2E4F2495B97FQ34389792-94E8E581-D0C0-48D0-B67E-A95B4E936248Q34428997-FDAB0EF8-2382-4289-BAF9-2DBD6818DE3EQ34571191-D05AD85E-06BD-4F95-8FDA-CE4B679EC2EDQ35127516-63E8D8A1-F76D-40C8-9666-FF1B2420784AQ35137398-9BE5F222-1264-4FE6-AE9E-6AA3D43E0892Q35573510-0E8F859F-10C1-4281-987D-A26F894C34BAQ35644631-27B9B680-8A79-40CD-96AD-C12DA5EBB536Q35762711-E4901FEA-18D5-4CF3-8844-CAF95E453DC9Q35819570-5F96229D-053E-4B3F-8553-E5431DEC4A68Q35821202-557601DE-DBF2-440B-AFE6-04A5115B3AD1Q35875899-88B5275E-B00C-4E57-B1E8-DD45BE176D35Q36026069-27A97619-8495-4C8A-AA5B-3612809E2310Q36162917-221E973E-045D-465A-A4AB-DC400E307CA3Q36342810-1D1C1C09-1D4B-47FC-B9F5-E5F554CA6A5FQ36380348-36BB1991-85EA-436E-B997-3505AFEDB768Q36382348-8EC56DB2-3F58-4999-B6B0-043B174B46D8Q36482515-9363BE9A-C263-4236-BED0-BEEC139D00A9Q36491823-D3F94AC1-AAED-49F2-B182-06633728A2C4Q36783331-844ABC8F-50E6-4E37-8913-569D33921131Q37098266-92873195-8345-4AD4-BD83-C17B29524732Q37209749-3BCCA667-A008-49E0-9A99-862E7014325DQ37274217-07D1FB0F-4F00-42D8-A9EF-F235D03D2026Q37320829-D85F8CAB-EF39-47A7-A198-F7487F851333Q37516516-7487B60E-614F-47C2-BB95-E775F5C20D63Q37713325-F35F597A-FC72-4A6F-9221-03C8C94B497EQ37799367-DFD8AC4A-46BD-466C-836C-9B48FB552833Q37844406-4C72D2A7-9F27-4788-866D-0F423E613C6B
P2860
Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Effects of antibiotic therapy ...... randomized controlled trials.
@ast
Effects of antibiotic therapy ...... randomized controlled trials.
@en
Effects of antibiotic therapy ...... randomized controlled trials.
@nl
type
label
Effects of antibiotic therapy ...... randomized controlled trials.
@ast
Effects of antibiotic therapy ...... randomized controlled trials.
@en
Effects of antibiotic therapy ...... randomized controlled trials.
@nl
prefLabel
Effects of antibiotic therapy ...... randomized controlled trials.
@ast
Effects of antibiotic therapy ...... randomized controlled trials.
@en
Effects of antibiotic therapy ...... randomized controlled trials.
@nl
P2093
P356
P1476
Effects of antibiotic therapy ...... randomized controlled trials.
@en
P2093
David L Brown
Jeffrey S Berger
Richard Andraws
P304
P356
10.1001/JAMA.293.21.2641
P407
P577
2005-06-01T00:00:00Z